drugset / Trial / NCT02483299

Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

NCT02483299

Phase 4 Completed 40 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to determine whether combined treatment with liraglutide and metformin is more effective than metformin as monotherapy in the treatment of obese women with polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients on combined treatment than in those on monotherapy.

Timeline

Start
2014-01
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Liraglutide Peptide 1.2 mg Subcutaneous
Comparator Metformin Small molecule 1000 mg Oral